|Articles|November 1, 1997

November 1997
Volume 3
Issue 11

Cardiovascular Drug Prescribing Patterns: Where is the Evidence of Improvement?

Author(s)Sarah A. Spinler, PharmD

Download PDF: Cardiovascular Drug Prescribing Patterns: Where is the Evidence of Improvement?

Articles in this issue

almost 29 years ago

Article

Empiric Examination of Physician Behavior in a Changing Healthcare Market

almost 29 years ago

Article

Healthcare Utilization Among Women with Eating Disordered Behavior

almost 29 years ago

Article

Postpartum Depression

almost 29 years ago

Article

Pulmonary Rehabilitation: An Overview with Evidence for Its Utility in Chronic Obstructive Pulmonary Disease

almost 29 years ago

Article

Pharmaceutical Considerations of Common Herbal Medicine

almost 29 years ago

Article

When Is a Cost-Effectiveness Claim Valid? How Much Should the FDA Care?

almost 29 years ago

Article

Treatment Patterns for Heart Failure in a Primary Care Environment

almost 29 years ago

Article

Referrals to General Internists and Internal Medicine Trainees in an Academic Medicine Practice

almost 29 years ago

Article

Enhancement of Compliance Among Patients with Hypertension

almost 29 years ago

Article

Incorporating Quality of Life Data into Managed Care Formulary Decisions: A Case Study with Salmeterol

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Cardiovascular Drug Prescribing Patterns: Where is the Evidence of Improvement?

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access